{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:18:46Z","timestamp":1788297526765,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":231,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306202\/2017-4"],"award-info":[{"award-number":["306202\/2017-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308107\/2013-6"],"award-info":[{"award-number":["308107\/2013-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijbiomac.2020.07.174","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T02:04:47Z","timestamp":1595037887000},"page":"66-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor"],"prefix":"10.1016","volume":"164","author":[{"given":"Pedro F.N.","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco E.S.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson L.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleverson D.T.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose T.A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0005","series-title":"Med. Microbiol","first-page":"587","article-title":"Coronaviruses","author":"Peiris","year":"2012"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0010","series-title":"Chapter 13 - Coronaviruses","first-page":"437","article-title":"Fenner and White\u2019s medical virology","author":"Burrell","year":"2017"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0025","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0040","series-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV)","author":"WHO","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0045","unstructured":"COVIDView weekly summary | CDC, (n.d.). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/covidview\/index.html (accessed April 26, 2020)."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0050","first-page":"2633","article-title":"Coronavirus disease 2019","volume":"2020","author":"Practice","year":"2019","journal-title":"World Heal. Organ."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virusres.2014.05.026","article-title":"Coronavirus reverse genetic systems: infectious clones and replicons","volume":"189","author":"Almaz\u00e1n","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0060","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspective","volume":"105951","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health \u2014 the latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0080","first-page":"105969","article-title":"Drug repositioning is an alternative for the treatment of coronavirus COVID-19","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0085","doi-asserted-by":"crossref","unstructured":"B. Robson, COVID-19 coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance, Comput. Biol. Med.. (n.d.). doi:https:\/\/doi.org\/10.1016\/J.COMPBIOMED.2020.103749.","DOI":"10.1016\/j.compbiomed.2020.103749"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0090","doi-asserted-by":"crossref","first-page":"101646","DOI":"10.1016\/j.tmaid.2020.101646","article-title":"A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease","author":"Hall","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0095","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.07.174_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s10156-003-0296-9","article-title":"Current concepts in SARS treatment","volume":"10","author":"Fujii","year":"2004","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0105","series-title":"Molecular Investigation of SARS \u2013 CoV-2 Proteins and","author":"Calligari","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biochi.2018.10.016","article-title":"Mo-CBP3-PepI, Mo-CBP3-PepII, and Mo-CBP3-PepIII are synthetic antimicrobial peptides active against human pathogens by stimulating ROS generation and increasing plasma membrane permeability","volume":"157","author":"Oliveira","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0115","first-page":"1","article-title":"Anticandidal activity of synthetic peptides: mechanism of action revealed by scanning electron and fluorescence microscopies and synergism effect with nystatin","author":"Lima","year":"2020","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0120","first-page":"183092","article-title":"RcAlb-PepII, a synthetic small peptide bioinspired in the 2S albumin from the seed cake of Ricinus communis, is a potent antimicrobial agent against Klebsiella pneumoniae and Candida parapsilosis","author":"Dias","year":"2019","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biochi.2020.05.016","article-title":"Synthetic antimicrobial peptides: from choice of the best sequences to action mechanisms","volume":"175","author":"Souza","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0130","series-title":"Proteins Struct. Funct. Genet., Proteins","first-page":"217","article-title":"Approaching the CAPRI challenge with an efficient geometry-based docking","author":"Inbar","year":"2005"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0145","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.3390\/ijms11103623","article-title":"SwarmDock and the use of normal modes in protein-protein docking","volume":"11","author":"Moal","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0150","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0155","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/acs.jctc.5b00356","article-title":"Improved peptide and protein torsional energetics with the OPLS-AA force field","volume":"11","author":"Robertson","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0160","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"issue":"e6","key":"10.1016\/j.ijbiomac.2020.07.174_bb0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0170","first-page":"2019","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"2019","author":"Jose","year":"2019","journal-title":"Lancet Respir."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0175","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0180","first-page":"1","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0185","article-title":"Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0190","doi-asserted-by":"crossref","first-page":"105998","DOI":"10.1016\/j.ijantimicag.2020.105998","article-title":"Arbidol: a potential antiviral drug for the treatment of SARS-CoV-2 by blocking the trimerization of viral spike glycoprotein?","author":"Vankadari","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2020.04.008","article-title":"Renin-angiotensin system at the heart of COVID-19 pandemic","author":"Alifano","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0205","doi-asserted-by":"crossref","unstructured":"A.E. Gorbalenya, S.C. Baker, R.S. Baric, R.J. de Groot, C. Drosten, A.A. Gulyaeva, B.L. Haagmans, C. Lauber, A.M. Leontovich, B.W. Neuman, D. Penzar, S. Perlman, L.L. Poon, D. Samborskiy, I.A. Sidorov, I. Sola, J. Ziebuhr, Severe Acute Respiratory Syndrome-related Coronavirus: The Species and Its Viruses-A Statement of the Coronavirus Study Group, (n.d.). doi:https:\/\/doi.org\/10.1101\/2020.02.07.937862.","DOI":"10.1101\/2020.02.07.937862"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0210","first-page":"R895","article-title":"Nicotine and the renin-angiotensin system","volume":"315","author":"Oakes","year":"2018","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0215","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/aps.2013.54","article-title":"Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0225","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2020.07.174_bb0230","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020339374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020339374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:05:54Z","timestamp":1788296754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020339374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"alternative-id":["S0141813020339374"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.174","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}